人生100年時代となった今、
一人一人が、より健康で豊かな社会生活を送れることが重要です。

Now that we live in an age of 100 years, it is important for each and every person to be able to lead a healthier and more prosperous social life.

新しい免疫促進剤HVJ-Eで遺伝子・核酸・細胞治療に貢献します。
イムノメディスン株式会社は、先端免疫療法剤の開発企業です。

We will contribute to gene, nucleic acid and cell therapy with the new immunostimulant HVJ-E.
Immunomedicine, Inc. is developing advanced immunomedicine drugs.

患者様及びご家族のQOLを出来る限り確保できるよう、

副作用を軽減できる治療薬の開発を目指します。

 

We aim to develop therapeutic drugs that can reduce side effects so that we can ensure the QOL of patients and their families as much as possible.

Mission
Message

Mission

当社のコア技術である(HVJ-E)は、RIG-Iを標的分子とする免疫促進剤であり、免疫療法剤のプラットフォーム技術です。遺伝子・核酸・細胞医薬などを組み合わせることで、癌などの従来の治療法では治せない疾患にも効果のある先端医薬を開発します。

Our core technology (HVJ-E) is an immunopromoter that targets RIG-I. It is a platform technology for the development of immunotherapeutic drugs. We are developing advanced drugs by the combination of gene, nucleic acid and cell therapy-drugs with our platform technology. Our drugs are expected to be effective for the treatment of incurable diseases such as cancers and drug resistant-infectious diseases.

Message

人生100歳時代となった今、一人一人が、より健康で豊かな社会生活を送れることが重要です。
ただ薬で癌や感染症などの病気を治すだけでなく、同時に患者さまやご家族様のQOLも向上する治療であることが重要と考えています。

Now that we live in an age of 100 years, it is important for each and every person to be able to lead a healthier and more prosperous social life. We believe that it is important not only to cure diseases such as cancer and infectious diseases with drugs, but also to improve quality of life (QOL) of patients and their families at the same time.

TOP